Related Experiment Videos
Xenogeneic rejection mechanisms shown by intravital microscopy
C Hammer1, R Linke, D Seehofer
1Institute for Surgical Research, Klinikum Grosshadern, Ludwig-Maximillians University, Munich, Germany.
Transplantation Proceedings
|December 29, 1998
Summary
This study reveals that xenogeneic liver damage begins in the periportal area, impacting microvascular perfusion. Combined platelet inhibitors and apheresis significantly improved blood flow in this xenogeneic model.
Area of Science:
- Transplantation immunology
- Vascular biology
- Hepatology
Background:
- Xenogeneic liver transplantation faces challenges with hyperacute rejection.
- Understanding microvascular perfusion dynamics is crucial for successful xenotransplantation.
- Previous models lacked precision in localizing xenogeneic damage within the liver.
Purpose of the Study:
- To investigate the precise location and dynamics of microvascular damage in a xenogeneic liver perfusion model.
- To assess the impact of perfusion failure on sinusoidal blood flow.
- To evaluate the efficacy of interventions in mitigating xenogeneic rejection.
Main Methods:
- Utilized an innovative in vivo microscopy (IVM) model for real-time observation of liver microcirculation.
- Quantified sinusoidal perfusion and calculated the ratio of perfused to unperfused sinusoids.
- Assessed the effects of various interventions, including platelet inhibitors and apheresis.
Main Results:
- Perfusion failure was localized to the periportal fields, where leukocytes first interact with foreign endothelium.
- During xenoperfusion, only 65% of sinusoids maintained blood flow, a significant reduction.
- Combined platelet inhibitors and apheresis demonstrated remarkable improvement in acinar perfusion.
Conclusions:
- The developed IVM model accurately analyzes microvascular and sinusoidal perfusion dynamics in xenogeneic settings.
- Early xenogeneic rejection involves non-specific interactions of leukocytes and thrombocytes, leading to microcirculatory collapse.
- Targeting these early cellular interactions may be key to improving xenograft survival.